Evidence map›Paper›PMID 33108389›Full record

ArticlePloS one2020

Differences in intrinsic aerobic capacity alters sensitivity to ischemia-reperfusion injury but not cardioprotective capacity by ischemic preconditioning in rats.

Marie Vognstoft Hjortbak, Thomas Skjærlund Grønnebæk, Nichlas Riise Jespersen, Thomas Ravn Lassen, Jacob Marthinsen Seefeldt, Pernille Tilma Tonnesen, Rebekka Vibjerg Jensen, Lauren Gerard Koch, Steven L Britton, Michael Pedersen and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Mitochondrial Kinase Signaling for Cardioprotection.International journal of molecular sciences · 2024
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Marie Vognstoft HjortbakDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0002-3434-1394
Thomas Skjærlund GrønnebækDepartment of Public Health, Aarhus University, Aarhus, Denmark.
Nichlas Riise JespersenDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0003-2502-2102
Thomas Ravn LassenDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Jacob Marthinsen SeefeldtDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0002-0633-5878
Pernille Tilma TonnesenDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Rebekka Vibjerg JensenDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Lauren Gerard KochDepartment of Physiology and Pharmacology, The University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United States of America.
Steven L BrittonDepartment of Anesthesiology, University of Michigan, Ann Arbor, Michigan, United States of America.
Michael PedersenDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Niels JessenSteno Diabetes Center Aarhus, Aahus University Hospital, Aarhus, Denmark.
Hans Erik BøtkerDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0001-6358-8962
Aarhus University · DKSteno Diabetes Centers · DKUniversity of Michigan · USUniversity of Toledo · US

Funding

Resource for Rat Genetic Models of Aerobic CapacityP40OD021331 · OD · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI KOCH, LAUREN GERARD · 2015 to 2019
$1.9M
NIH HHS P40 OD021331
6 · The paper itself

Abstract

introductionAerobic capacity is a strong predictor of cardiovascular mortality. Whether aerobic capacity influences myocardial ischemia and reperfusion (IR) injury is unknown. PURPOSE: To investigate the impact of intrinsic differences in aerobic capacity and the cardioprotective potential on IR injury.

methodsWe studied hearts from rats developed by selective breeding for high (HCR) or low (LCR) capacity for treadmill running. The rats were randomized to: (1) control, (2) local ischemic preconditioning (IPC) or (3) remote ischemic preconditioning (RIC) followed by 30 minutes of ischemia and 120 minutes of reperfusion in an isolated perfused heart model. The primary endpoint was infarct size. Secondary endpoints included uptake of labelled glucose, content of selected mitochondrial proteins in skeletal and cardiac muscle, and activation of AMP-activated kinase (AMPK).

resultsAt baseline, running distance was 203±7 m in LCR vs 1905±51 m in HCR rats (p<0.01). Infarct size was significantly lower in LCR than in HCR controls (49±5% vs 68±5%, p = 0.04). IPC reduced infarct size by 47% in LCR (p<0.01) and by 31% in HCR rats (p = 0.01). RIC did not modulate infarct size (LCR: 52±5, p>0.99; HCR: 69±6%, p>0.99, respectively). Phosphorylaion of AMPK did not differ between LCR and HCR controls. IPC did not modulate cardiac phosphorylation of AMPK. Glucose uptake during reperfusion was similar in LCR and HCR rats. IPC increased glucose uptake during reperfusion in LCR animals (p = 0.02). Mitochondrial protein content in skeletal muscle was lower in LCR than in HCR (0.77±0.10 arbitrary units (AU) vs 1.09±0.07 AU, p = 0.02), but not in cardiac muscle.

conclusionAerobic capacity is associated with altered myocardial sensitivity to IR injury, but the cardioprotective effect of IPC is not. Glucose uptake, AMPK activation immediately prior to ischemia and basal mitochondrial protein content in the heart seem to be of minor importance as underlying mechanisms for the cardioprotective effects.

Indexed as

Ischemic Preconditioning, MyocardialAerobiosisAMP-Activated Protein KinasesAnimalsGlucoseMitochondrial ProteinsModels, AnimalMuscle, SkeletalMyocardial Reperfusion InjuryMyocardiumRatsRunningAMP-Activated Protein KinasesGlucoseMitochondrial Proteins

Identifiers

PMID33108389
PMCPMC7591019
OpenAlexW3096160232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.